Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 2
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Impact of Azithromycin-Based Extended-Spectrum Antibiotic Prophylaxis on Noninfectious Cesarean Wound Complications.
Ausbeck EB, Jauk VC, Boggess KA, Saade GR, Longo S, Clark EAS, Esplin S, Cleary K, Wapner R, Letson K, Owens M, Abramovici A, Ambalavanan N, Szychowski JM, Andrews W, Tita ATN; Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium. Ausbeck EB, et al. Am J Perinatol. 2019 Jul;36(9):886-890. doi: 10.1055/s-0039-1679914. Epub 2019 Feb 19. Am J Perinatol. 2019. PMID: 30780190
Risk Factors for Postcesarean Maternal Infection in a Trial of Extended-Spectrum Antibiotic Prophylaxis.
Boggess KA, Tita A, Jauk V, Saade G, Longo S, Clark EAS, Esplin S, Cleary K, Wapner R, Letson K, Owens M, Blackwell S, Beamon C, Szychowski JM, Andrews W; Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium. Boggess KA, et al. Obstet Gynecol. 2017 Mar;129(3):481-485. doi: 10.1097/AOG.0000000000001899. Obstet Gynecol. 2017. PMID: 28178058 Free PMC article. Clinical Trial.
Skin preparation type and post-cesarean infection with use of adjunctive azithromycin prophylaxis.
Ausbeck EB, Jauk VC, Boggess KA, Saade G, Longo S, Esplin S, Cleary K, Wapner R, Letson K, Owens M, Blackwell S, Ambalavanan N, Szychowski JM, Andrews W, Tita ATN; Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium. Ausbeck EB, et al. J Matern Fetal Neonatal Med. 2022 Jul;35(14):2690-2694. doi: 10.1080/14767058.2020.1797665. Epub 2020 Jul 29. J Matern Fetal Neonatal Med. 2022. PMID: 32727231 Clinical Trial.
Institutional Protocols for Vaginal Preparation With Antiseptic Solution and Surgical Site Infection Rate in Women Undergoing Cesarean Delivery During Labor.
La Rosa M, Jauk V, Saade G, Boggess K, Longo S, Clark EAS, Esplin S, Cleary K, Wapner R, Letson K, Owens MY, Blackwell S, Szychowski JM, Andrews WW, Tita AT; Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium. La Rosa M, et al. Obstet Gynecol. 2018 Aug;132(2):371-376. doi: 10.1097/AOG.0000000000002745. Obstet Gynecol. 2018. PMID: 29995743 Free PMC article. Clinical Trial.
Incidence and Risk Factors for Hospital Readmission or Unexpected Visits in Women Undergoing Unscheduled Cesarean Delivery.
La Rosa M, Jauk V, Saade GR, Boggess K, Longo S, Clark EAS, Esplin S, Cleary K, Wapner R, Letson K, Owens MY, Blackwell S, Szychowski JM, Andrews W, Tita AT; Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium. La Rosa M, et al. Am J Perinatol. 2019 Sep;36(11):1115-1119. doi: 10.1055/s-0039-1683391. Epub 2019 Mar 15. Am J Perinatol. 2019. PMID: 30877684 Clinical Trial.